South Korea signs for extra 40 million Covid-19 vaccine doses with Pfizer

The country said that it had also secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.

South Korea said on Saturday it signed a contract with Pfizer Inc to purchase an additional 40 million doses of its COVID-19 vaccine amid fears of spiking infections at home.

With this the current amount of Pfizer vaccines in the country will come to 66 million doses. (Reuters)

That brings the current amount of Pfizer vaccines to 66 million doses, it said in a statement.

It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.